Blount Sally E. 4

What Happened

• Sally E. Blount, a director of Abbott Laboratories (ABT), received a grant of 2,286 restricted stock units (transaction code A) on April 24, 2026. The units were granted at $0.00 (typical for awards) and are payable in Abbott common shares under the company's 2017 Incentive Stock Program.

Key Details

• Transaction date: 2026-04-24 (reported on Form 4 filed 2026-04-28).
• Security and amount: 2,286 restricted stock units; acquisition price listed as $0.00 (award).
• Shares owned after transaction: Not specified in this Form 4.
• Footnote: RSUs will be paid one-for-one in Abbott common shares upon the earlier of the director's separation from service, death, or a change in control per the Program.
• Filing timeliness: Report filed 4 days after the grant (appears within typical 2-business-day reporting window for insiders).

Context

• RSU grants to non-employee directors are common compensation and are distinct from open-market purchases or sales; they do not by themselves indicate a director buying or selling stock for investment reasons.
• This was an equity award (not a purchase or sale). The award vests/settles under specified events rather than immediately converting to tradable shares.